Institutional Ownership Arrowhead Pharmaceuticals, Inc. (ARWR)
This table provides information about the institutional ownership of Arrowhead Pharmaceuticals, Inc. (ARWR). We have compiled data on the 304 institutions that hold shares in the stock, with a total of 95.8 Million shares, which have been reported (via 13F filing form) to have a value of $1.32 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Farallon Capital Management LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
628,800
shares
|
$8.69 Million
0.06% of portfolio
|
Q4 2024
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
575,974
shares
|
$7.96 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.48%
|
|
|
Abrdn PLC
|
Jan 24, 2025 Q4 2024 |
450,075
shares
|
$6.22 Million
0.02% of portfolio
|
Q4 2024
Added 12.2%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
430,700
shares
|
$5.95 Million
0.02% of portfolio
|
Q4 2024
Added 330.7%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Feb 14, 2025 Q4 2024 |
418,246
shares
|
$5.78 Million
0.0% of portfolio
|
Q4 2024
Added 45.59%
|
|
|
Privium Fund Management B.V.
|
Feb 10, 2025 Q4 2024 |
380,586
shares
|
$5.26 Million
1.64% of portfolio
|
Q4 2024
Added 14.17%
|
|
|
Rhumbline Advisers
Boston, MA |
Jan 30, 2025 Q4 2024 |
380,344
shares
|
$5.26 Million
0.01% of portfolio
|
Q4 2024
Added 2.12%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
372,749
shares
|
$5.15 Million
0.01% of portfolio
|
Q4 2024
Added 265.97%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
367,998
shares
|
$5.09 Million
0.0% of portfolio
|
Q4 2024
Reduced 68.75%
|
|
|
Center Book Partners LP
Greenwich, CT |
Feb 13, 2025 Q4 2024 |
350,473
shares
|
$4.84 Million
0.43% of portfolio
|
Q4 2024
Reduced 11.18%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
332,749
shares
|
$4.6 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.76%
|
|
|
Hound Partners, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
325,525
shares
|
$4.5 Million
2.42% of portfolio
|
Q4 2024
Reduced 14.04%
|
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
312,560
shares
|
$4.32 Million
0.0% of portfolio
|
Q4 2024
Added 13.0%
|
|
|
Affinity Asset Advisors, LLC
New York, NY |
Feb 13, 2025 Q4 2024 |
300,000
shares
|
$4.15 Million
1.01% of portfolio
|
Q4 2024
Reduced 7.69%
|
|
|
Principal Financial Group Inc
Des Moines, IA |
Jan 31, 2025 Q4 2024 |
288,884
shares
|
$3.99 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Silvercrest Asset Management Group LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
280,511
shares
|
$3.88 Million
0.04% of portfolio
|
Q4 2024
Added 24.73%
|
|
|
Integral Health Asset Management, LLC
|
Feb 14, 2025 Q4 2024 |
275,000
shares
|
$3.8 Million
0.46% of portfolio
|
Q4 2024
New holding
|
|
|
Alliancebernstein L.P.
New York, NY |
Feb 12, 2025 Q4 2024 |
265,482
shares
|
$3.67 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.17%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Feb 14, 2025 Q4 2024 |
258,964
shares
|
$3.58 Million
0.0% of portfolio
|
Q4 2024
Added 17.03%
|
|
|
Johnson & Johnson
New Brunswick, NJ |
Feb 13, 2025 Q4 2024 |
247,598
shares
|
$3.42 Million
1.59% of portfolio
|
Q3 2022
Reduced 80.36%
|
|
|
Legal & General Group PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
245,272
shares
|
$3.39 Million
0.0% of portfolio
|
Q3 2024
Reduced 1.4%
|
|
|
Mirae Asset Global Etfs Holdings Ltd.
Central, K3 |
Feb 14, 2025 Q4 2024 |
242,702
shares
|
$3.35 Million
0.01% of portfolio
|
Q4 2024
Added 15.87%
|
|
|
Altium Capital Management LP
New York, NY |
Feb 13, 2025 Q4 2024 |
230,257
shares
|
$3.18 Million
1.44% of portfolio
|
Q4 2024
Reduced 35.14%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Feb 14, 2025 Q4 2024 |
224,988
shares
|
$3.11 Million
0.0% of portfolio
|
Q4 2024
Added 2.61%
|
|
|
Swiss National Bank
Zurich, V8 |
Feb 10, 2025 Q4 2024 |
220,000
shares
|
$3.04 Million
0.0% of portfolio
|
Q4 2024
Added 0.78%
|